Crossmark Global Holdings, Inc.
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1539204
HOUSTON, TX
Position in PTGX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$415,423
+$47,683 QoQ
Shares Held
3,389
-2.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#228
of 343 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $48,601,060 across 36 Biotechnology names. PTGX ranks #21 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
89,139 | $10,104,797 | |
| 2 | ARGX |
Argenx SE
|
9,684 | $8,984,524 | |
| 3 | EXEL |
Exelixis, Inc.
|
74,817 | $4,070,792 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
10,755 | $3,064,852 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
51,220 | $2,930,808 | |
| 6 | BNTX |
BioNTech SE
|
20,934 | $1,947,908 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,237 | $1,743,899 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,828 | $1,404,752 |
All Filings in PTGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415,423 | 3,389 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $367,740 | 3,489 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $345,866 | 3,960 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $263,461 | 3,966 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $224,672 | 4,065 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||